620 related articles for article (PubMed ID: 22396543)
1. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.
Lv LH; Wan YL; Lin Y; Zhang W; Yang M; Li GL; Lin HM; Shang CZ; Chen YJ; Min J
J Biol Chem; 2012 May; 287(19):15874-85. PubMed ID: 22396543
[TBL] [Abstract][Full Text] [Related]
2. Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells.
Xiao W; Dong W; Zhang C; Saren G; Geng P; Zhao H; Li Q; Zhu J; Li G; Zhang S; Ye M
Eur J Med Res; 2013 Dec; 18(1):61. PubMed ID: 24359553
[TBL] [Abstract][Full Text] [Related]
3. A hyposensitive anticancer drug induces higher surface expression and release of heat shock proteins in a human hepatocellular carcinoma cell line.
Yang M; Xu Z; Wang Q; Zhang AQ; Min J
Mol Med Rep; 2015 Aug; 12(2):2879-85. PubMed ID: 25955691
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
Gastpar R; Gehrmann M; Bausero MA; Asea A; Gross C; Schroeder JA; Multhoff G
Cancer Res; 2005 Jun; 65(12):5238-47. PubMed ID: 15958569
[TBL] [Abstract][Full Text] [Related]
5. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells.
Elsner L; Flügge PF; Lozano J; Muppala V; Eiz-Vesper B; Demiroglu SY; Malzahn D; Herrmann T; Brunner E; Bickeböller H; Multhoff G; Walter L; Dressel R
J Cell Mol Med; 2010 Apr; 14(4):992-1002. PubMed ID: 20569278
[TBL] [Abstract][Full Text] [Related]
6. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70.
Böttger E; Multhoff G; Kun JF; Esen M
PLoS One; 2012; 7(3):e33774. PubMed ID: 22438997
[TBL] [Abstract][Full Text] [Related]
8. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.
Elsner L; Muppala V; Gehrmann M; Lozano J; Malzahn D; Bickeböller H; Brunner E; Zientkowska M; Herrmann T; Walter L; Alves F; Multhoff G; Dressel R
J Immunol; 2007 Oct; 179(8):5523-33. PubMed ID: 17911639
[TBL] [Abstract][Full Text] [Related]
9. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
10. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
11. Heat treatment of hepatocellular carcinoma cells: increased levels of heat shock proteins 70 and 90 correlate with cellular necrosis.
Schueller G; Paolini P; Friedl J; Stift A; Dubsky P; Bachleitner-Hofmann T; Jakesz R; Gnant M
Anticancer Res; 2001; 21(1A):295-300. PubMed ID: 11299751
[TBL] [Abstract][Full Text] [Related]
12. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.
Lim SO; Park SG; Yoo JH; Park YM; Kim HJ; Jang KT; Cho JW; Yoo BC; Jung GH; Park CK
World J Gastroenterol; 2005 Apr; 11(14):2072-9. PubMed ID: 15810071
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
[TBL] [Abstract][Full Text] [Related]
14. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PR/SET domain 10 underlies natural killer cell dysfunction in hepatocellular carcinoma.
Han J; Ke C; Jiang B; Zhou H; Xu H; Xie X
Clin Exp Immunol; 2021 Dec; 206(3):366-377. PubMed ID: 34562314
[TBL] [Abstract][Full Text] [Related]
17. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70.
Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD
J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells.
Huang YX; Chen XT; Guo KY; Li YH; Wu BY; Song CY; He YJ
J Immunother; 2017 Jun; 40(5):164-174. PubMed ID: 28452850
[TBL] [Abstract][Full Text] [Related]
19. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression.
Sun X; Sui Q; Zhang C; Tian Z; Zhang J
Mol Cancer Ther; 2013 Dec; 12(12):2885-96. PubMed ID: 24107450
[TBL] [Abstract][Full Text] [Related]
20. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
Kamiya T; Chang YH; Campana D
Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
